Alterity.png
Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
March 26, 2024 10:25 ET | ALTERITY THERAPEUTICS LIMITED
MELBOURNE, Australia and SAN FRANCISCO, March 27, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company...
Longeveron Logo.jpg
Longeveron Reports Year-End 2023 Results and Provides Corporate Update
February 27, 2024 16:05 ET | Longeveron
Company Announces 2024 Strategic Priorities Focused on Advancement of Lomecel-B™ in Hypoplastic Left Heart Syndrome ELPIS II Phase 2 Trial of Lomecel-B™ in HLHS Continues Enrollment; Completion of...
Transparency Market Research
Veterinary MRI Systems Market Size is Projected to Reach USD 193.0 million by 2031, at a CAGR 6.6% | States Transparency Market Research, Inc.
February 08, 2024 05:10 ET | Transparency Market Research
Wilmington, Delaware, United States, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The veterinary MRI systems market was worth US$ 106.6 million in 2022. A CAGR of 6.6% is...
ZimVie_Logo.png
ZimVie は日本における次世代TSX®インプラントの発売を発表
February 07, 2024 16:05 ET | ZimVie Inc.
コロラド州ウェストミンスター, Feb. 08, 2024 (GLOBE NEWSWIRE) -- 歯科および脊椎外科領域におけるグローバルライフサイエンスのリーディングカンパニーであるZimVie Inc.(Nasdaq:...
ZimVie_Logo.png
ZimVie Announces Launch of Next-Generation TSX® Implant in Japan
February 07, 2024 16:05 ET | ZimVie Inc.
WESTMINSTER, Colo., Feb. 07, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the launch of the TSX® Implant in...
Philippine Light Truck Industry Market
Philippines Light Truck Market Report 2023-2032: Safeguard Duty Lifted, e-Commerce Boosts Light Truck Demand
January 30, 2024 05:23 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Philippines Light Truck Industry Research Report 2023-2032" report has been added to ResearchAndMarkets.com's offering. In 2021, the Philippine...
Longeveron Logo.jpg
Longeveron Announces Additional Positive Clinical Data and Imaging Biomarker Results from the CLEAR MIND Phase 2a Trial of Lomecel-B™ in the Treatment of Mild Alzheimer’s Disease
December 20, 2023 08:00 ET | Longeveron
New clinical data showed that Lomecel-B™ improved cognitive function in multiple measures in a dose-response fashion Caregiver ratings documented improved quality of life in Lomecel-B™ treated...
Matic’s Year-End Rep
Matic’s Year-End Report Unveils Continued Challenges in 2024 Home Insurance Landscape: Record Premiums, Increased Deductibles, and Industry-Wide Impact on Mortgage Lenders
December 12, 2023 11:54 ET | Matic
Columbus, Ohio, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Matic, a leading digital insurtech platform, today released its annual year-end trends and predictions report. The report analyzes major trends that...
DTI Logo.jpg
Drilling Tools International Reports Third Quarter 2023 Financial Results
November 13, 2023 07:00 ET | Drilling Tools International Corp.
HOUSTON, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Drilling Tools International Corp., (“DTI” or the “Company”) (Nasdaq: DTI), a leading oilfield services company that manufactures and provides a...
SWTXlogo.jpg
SpringWorks Therapeutics Announces Presentation of Additional Data from Phase 3 DeFi Trial of Nirogacestat in Adults with Desmoid Tumors at the 2023 CTOS Annual Meeting
November 01, 2023 06:30 ET | SpringWorks Therapeutics, Inc.
- Nirogacestat Treatment Demonstrated Rapid and Sustained Improvements in Functional Status Compared to Placebo Across Multiple Assessment Tools - STAMFORD, Conn., Nov. 01, 2023 (GLOBE NEWSWIRE)...